drugset / Trial / NCT00856934

Effect of Platelet Rich Plasma and Keratinocyte Suspensions on Wound Healing

NCT00856934 ↗

Phase 1 Completed 45 enrolled Centre Hospitalier Universitaire Vaudois
RandomizedParallel-groupOpen-labelTreatment

Summary

This prospective randomized trial evaluated the impact of autologous keratinocytes suspended in platelet concentrates on healing skin graft donor site wounds. It was hypothesized that the treatment would speed and improve wound healing.

Timeline

Start
2005-06
Primary completion
2006-03
Completion
—

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Control vs PRP vs PRP+K; p = 0.05; ANOVA NCT00856934 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Keratinocyte suspension Cell therapy — Topical
Subject Platelet Rich Plasma Other / unclassified — Topical

Indications

No indication recorded.